778 results on '"Sanguineti G"'
Search Results
152. Radio-chemotherapy for Head and Neck Carcinoma
153. Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy
154. Adaptive Replanning After 5 Treatment Fractions in Prostate Patients With Implanted Markers Impacts on Setup Accuracy
155. PO-0705: IGRT tracking prostate fiducials increases risk of acute diarrhea during whole pelvis IMRT/VMAT for prostate cancer
156. PD-0583: Parotid density and volume variation in IMRT for head-neck cancer: predicting final changes from early variations
157. PO-0663: Early density and volume variations of parotid glands are correlated with acute xerostomia during IMRT for HN cancer
158. OC-0552: Texture analysis for the characterization of structural variations in parotid glands during radiotherapy
159. Feasibility of a biphasic accelerated schedule in the post-operative radiotherapy of head and neck squamous cell carcinomas
160. Tomografia computerizzata e risonanza magnetica nella patologia del distretto testa e collo
161. Cell kinetics parameters as prognostic factors for multimodality treatments of head and neck tumors
162. Mid-treatment Volumetric Change of Parotids Is an Independent Predictor of Long-term Xerostomia
163. PEG Dependence After IMRT for Oropharyngeal Cancer: Different Impact of CHT, Oral Mucosa, and Superior Constrictor Dose-Volume Parameters Between Short (>3 months) and Long (>7 months) Dependence
164. Computed 88% TCP Dose for SBRT of NSCLC
165. SU-C-211-03: Using OVH and IMRT Plan Data to Automate VMAT Planning: A Head-And-Neck Study
166. SP-0263 ASSESSMENT OF HEAD-NECK TOXICITY USING CT
167. PO-0717 PREDICTING LONG TERM PEG DEPENDENCE AFTER IMRT +/− CONCOMITANT CHEMOTHERAPY FOR OROPHARYNGEAL CANCER
168. PD-0398 DENSITY VARIATION OF PAROTID GLANDS DURING IMRT: CORRELATION WITH TREATMENT PARAMETERS AND PAROTID SHRINKAGE
169. OC-0191 PAROTID DEFORMATION DURING IMRT FOR HEAD-NECK CANCER CORRELATES WITH CLINICAL AND DOSIMETRY INFORMATION
170. EP-1539 VOLUMETRIC MODULATED ARC THERAPY FOR STEREOTACTIC SPINE BODY RADIOTHERAPY: A PLANNING STUDY
171. 119 QUANTITATIVE PARAMETERS OF PAROTID DEFORMATION DURING IMRT FOR HEAD-NECK CANCER CORRELATE WITH INDIVIDUALLY ASSESSED CLINICAL AND DOSIMETRY INFORMATION
172. Ruolo della radioterapia nei tumori della glottide (T1-T2 N0), terapia di elezione?
173. Defining the Risk of Extra-Capsular Extension (ECE) in Patients with Early T-stage, Node-positive, HPV-related Oropharyngeal Carcinoma
174. Fully Automated IMRT Planning is Feasible for Head and Neck Cancer: A Prospective Study using an Overlap Volume Histogram (OVH) Strategy
175. On the Feasibility of using Overlap Volume Histogram and DVH Data of Prior IMRT Plans to Guide Smart Arc-based Volumetric Modulated Arc Therapy Treatment Planning
176. Chemoradiotherapy for HPV-related Oropharyngeal SCC
177. Defining the Risk of Involvement for Each Neck Nodal Level in Patients with Early T-Stage/Node-positive/HPV-related Oropharyngeal Carcinoma
178. Lymph node density and response to induction TPF in patients with HPV-related head and neck cancer.
179. 507 speaker IMAGE-BASED DOSE-VOLUME EFFECTS PREDICTION
180. 1144 poster PREDICTORS OF LONG-TERM PEG DEPENDENCE AFTER EXCLUSIXE IMRT INCLUDING KINETIC OF ACUTE TOXICITY
181. 98 oral QUANTITATIVE PARAMETERS OF PAROTID DEFORMATION ARE HIGHLY CORRELATED TO DVH: EVIDENCE OF A DOSE-BATH EFFECT AROUND 1 5GY
182. 816 poster ALTERNATING CHEMO-RADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCER: 30 YEARS OF EXPERIENCE IN GENOA
183. [Accelerated radiotherapy with the concomitant-boost technic in patients with squamous cell carcinoma of the head and neck]
184. La radioterapia per la cura delle neoplasie del paziente anziano
185. Cell kinetics analysis by in vivo bromodeoxyuridine and Flow Cytometry in head and neck squamous cell carcinoma in oral oncology
186. An OVH-driven Automated IMRT Treatment Planning System
187. Effect of Radiotherapy and Chemotherapy on the Risk of Mucositis during IMRT for Oropharyngeal Cancer
188. Predictors of Laryngeal Edema during IMRT for Head and Neck Cancer
189. Oncospace: All Patients on Trial for Analysis of Outcomes, Toxicities, and IMRT Plan Quality
190. TU-A-BRA-03: Knowledge-Based and Patient-Geometry Specific IMRT Treatment Planning
191. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy]
192. Preliminary evidence of prognostic significance in loco-regional control of 'Tpot' in head and neck tumors treated by primary radiotherapy
193. Predicting Parotid Shrinkage during IMRT for Head and Neck Cancer: Independent Impact of Anatomical/Clinical and Dosimetric Parameters
194. Dose/Time Volume Histograms of the Oral Mucosa are Predictive of the Use of PEG During IMRT for Oropharyngeal Carcinoma
195. Volumetric Change of Positive Lymph Nodes during IMRT for HPV-associated Oropharyngeal SCC
196. Evaluating Parotid Gland Shrinkage during IMRT for Oropharyngeal SCC
197. A Data-driven Approach to Generating Achievable DVH Objectives in IMRT Treatment Planning
198. ADAPTIVE RADIOTHERAPY TO PROGRESSIVE ANATOMICAL CHANGES
199. A TWO – VARIABLES LINEAR MODEL OF PAROTID SHRINKAGE DURING IMRT FOR HEAD AND NECK CANCER
200. MO-D-BRB-03: Using a Database of Patient Geometric and Dosimetric Information for Quantitative IMRT Plan Quality Control
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.